The production base of Beimei mainly undertakes the production of self-developed products and CMO orders for products licensed from Europe and the United States, and provides customized services to meet the seamless connection from preclinical to commercialization. Complying with cGMP, EU and FDA requirements to ensure product effectiveness and safety.
Lianyungang incubated and amassed a number of leading pharmaceutical companies in China such as Hengrui Pharma, Chiatai Tianqing，Hansoh Pharma and Kanion Pharma, where has become the national largest pharmaceutical export base to the US and an important national innovative drug production base, with a total pharmaceutical output value of more than 100 billion yuan.
